Effects of cerivastatin on adrenergic pathways, hypertrophic growth and TGFbeta expression in adult ventricular cardiomyocytes

European Journal of Cell Biology

Volumn 91, Issue 5, 2012, Pages 367-374

  Maxeiner, Hagen ^b   Abdallah, Yaser ^a   Kuhlmann, Christoph Rüdiger Wolfram ^c   Schlüter, Klaus Dieter ^a   Wenzel, Sibylle ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Isoprenaline; NAD(P)H oxidase; P38 MAP kinase; Phenylephrine; Rac

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CERIVASTATIN; DICHLOROFLUORESCEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; RAC PROTEIN; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL GROWTH; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; FLUORESCENCE ANALYSIS; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE; HYPERTROPHY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HEART FAILURE; HEART VENTRICLES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MAP KINASE SIGNALING SYSTEM; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PYRIDINES; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; TRANSFORMING GROWTH FACTOR BETA;

EID: 84857788681     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2011.12.006     Document Type: Article

References (50)

1. Adiga I.K., Nair R.R. Multiple signaling pathways coordinately mediate reactive oxygen species dependent cardiomyocyte hypertrophy. Cell Biochem. Funct. 2008, 26:346-351.
2. Andersson D.C., Fauconnier J., Yamada T., Lacampagne A., Zhang S.J., Katz A., Westerblad H. Mitochondrial production of reactive oxygen species contributes to the beta-adrenergic stimulation of mouse cardiomyocytes. J. Physiol. 2011, 589:1791-1801.
3. Anwar A., Taimor G., Korkususz H., Schreckenberg R., Berndt T., Abdallah Y., Piper H.M., Schluter K.D. PKC-independent signal transduction pathways increase SERCA2 expression in adult rat cardiomyocytes. J. Mol. Cell. Cardiol. 2005, 39:911-919.
4. Bokoch G.M., Knaus U.G. NADPH oxidases: not just for leukocytes anymore!. Trends Biochem. Sci. 2003, 28:502-508.
5. Boluyt M.O., Bing O.H., Lakatta E.G. The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. Eur. Heart J. 1995, 16(Suppl. N):19-30.
6. Boluyt M.O., Zheng J.S., Younes A., Long X., O'Neill L., Silverman H., Lakatta E.G., Crow M.T. Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase. Circ. Res. 1997, 81:176-186.
7. Bowman J.C., Steinberg S.F., Jiang T., Geenen D.L., Fishman G.I., Buttrick P.M. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. J. Clin. Invest. 1997, 100:2189-2195.
8. Brandes R.P., Weissmann N., Schroder K. NADPH oxidases in cardiovascular disease. Free Radic. Biol. Med. 2010, 49:687-706.
9. Briest W., Homagk L., Rassler B., Ziegelhoffer-Mihalovicova B., Meier H., Tannapfel A., Leiblein S., Saalbach A., Deten A., Zimmer H.G. Norepinephrine-induced changes in cardiac transforming growth factor-beta isoform expression pattern of female and male rats. Hypertension 2004, 44:410-418.
10. Brown J.H., Del Re D.P., Sussman M.A. The Rac and Rho hall of fame: a decade of hypertrophic signaling hits. Circ. Res. 2006, 98:730-742.
11. Clerk A., Pham F.H., Fuller S.J., Sahai E., Aktories K., Marais R., Marshall C., Sugden P.H. Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1. Mol. Cell. Biol. 2001, 21:1173-1184.
12. Hassanain H.H., Gregg D., Marcelo M.L., Zweier J.L., Souza H.P., Selvakumar B., Ma Q., Moustafa-Bayoumi M., Binkley P.F., Flavahan N.A., Morris M., Dong C., Goldschmidt-Clermont P.J. Hypertension caused by transgenic overexpression of Rac1. Antioxid. Redox Signal. 2007, 9:91-100.
13. He Q., Wu G., Lapointe M.C. Isoproterenol and cAMP regulation of the human brain natriuretic peptide gene involves Src and Rac. Am. J. Physiol. Endocrinol. Metab. 2000, 278:E1115-E1123.
14. Ito M., Adachi T., Pimentel D.R., Ido Y., Colucci W.S. Statins inhibit beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism. Circulation 2004, 110:412-418.
15. Koshkin V., Lotan O., Pick E. The cytosolic component p47(phox) is not a sine qua non participant in the activation of NADPH oxidase but is required for optimal superoxide production. J. Biol. Chem. 1996, 271:30326-30329.
16. Lai K.B., Sanderson J.E., Yu C.M. Suppression of collagen production in norepinephrine stimulated cardiac fibroblasts culture: differential effect of alpha and beta-adrenoreceptor antagonism. Cardiovasc. Drugs Ther. 2009, 23:271-280.
17. Lee T.M., Chen C.C., Hsu Y.J. Differential effects of NADPH oxidase and xanthine oxidase inhibition on sympathetic reinnervation in postinfarct rat hearts. Free Radic. Biol. Med. 2011, 50:1461-1470.
18. Luo J.D., Xie F., Zhang W.W., Ma X.D., Guan J.X., Chen X. Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes. Br. J. Pharmacol. 2001, 132:159-164.
19. Melchert R.B., Liu H., Granberry M.C., Kennedy R.H. Lovastatin inhibits phenylephrine-induced ERK activation and growth of cardiac. Cardiovasc. Toxicol. 2001, 1:237-252.
20. Morikawa-Futamatsu K., Adachi S., Maejima Y., Tamamori-Adachi M., Suzuki J., Kitajima S., Ito H., Isobe M. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1. Life Sci. 2006, 79:1380-1390.
21. Mufti S., Wenzel S., Euler G., Piper H.M., Schluter K.D. Angiotensin II-dependent loss of cardiac function: mechanisms and pharmacological targets attenuating this effect. J. Cell Physiol. 2008, 217:242-249.
22. Muhlhauser U., Zolk O., Rau T., Munzel F., Wieland T., Eschenhagen T. Atorvastatin desensitizes beta-adrenergic signaling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits. FASEB J. 2006, 20:785-787.
23. Nishio E., Kanda Y., Watanabe Y. Alpha1-adrenoreceptor stimulation causes vascular smooth muscle cell hypertrophy: a possible role for isoprenoid intermediates. Eur. J. Pharmacol. 1998, 347:125-130.
24. Nisimoto Y., Freeman J.L., Motalebi S.A., Hirshberg M., Lambeth J.D. Rac binding to p67(phox). Structural basis for interactions of the Rac1 effector region and insert region with components of the respiratory burst oxidase. J. Biol. Chem. 1997, 272:18834-18841.
25. O'Callaghan C.J., Williams B. The regulation of human vascular smooth muscle extracellular matrix protein production by alpha- and beta-adrenoceptor stimulation. J. Hypertens. 2002, 20:287-294.
26. Omura T., Kim S., Takeuchi K., Iwao H., Takeda T. Transforming growth factor beta 1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin system. Cardiovasc. Res. 1994, 28:1835-1842.
27. Peng H., Carretero O.A., Vuljaj N., Liao T.D., Motivala A., Peterson E.L., Rhaleb N.E. Angiotensin-converting enzyme inhibitors: a new mechanism of action. Circulation 2005, 112:2436-2445.
28. Pinson A., Schluter K.D., Zhou X.J., Schwartz P., Kessler-Icekson G., Piper H.M. Alpha- and beta-adrenergic stimulation of protein synthesis in cultured adult ventricular cardiomyocytes. J. Mol. Cell. Cardiol. 1993, 25:477-490.
29. Pracyk J.B., Tanaka K., Hegland D.D., Kim K.S., Sethi R., Rovira I.I., Blazina D.R., Lee L., Bruder J.T., Kovesdi I., Goldshmidt-Clermont P.J., Irani K., Finkel T. A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy. J. Clin. Invest. 1998, 102:929-937.
30. Rohde S., Sabri A., Kamasamudran R., Steinberg S.F. The alpha(1)-adrenoceptor subtype- and protein kinase C isoform-dependence of Norepinephrine's actions in cardiomyocytes. J. Mol. Cell. Cardiol. 2000, 32:1193-1209.
31. Ruf S., Piper M., Schluter K.D. Specific role for the extracellular signal-regulated kinase pathway in angiotensin II-but not phenylephrine-induced cardiac hypertrophy in vitro. Pflugers Arch. 2002, 443:483-490.
32. Sadoshima J., Qiu Z., Morgan J.P., Izumo S. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling. Circ. Res. 1995, 76:1-15.
33. Schafer M., Schafer C., Michael Piper H., Schluter K.D. Hypertrophic responsiveness of cardiomyocytes to alpha- or beta-adrenoceptor stimulation requires sodium-proton-exchanger-1 (NHE-1) activation but not cellular alkalization. Eur. J. Heart Fail. 2002, 4:249-254.
34. Schluter K.D., Goldberg Y., Taimor G., Schafer M., Piper H.M. Role of phosphatidylinositol 3-kinase activation in the hypertrophic growth of adult ventricular cardiomyocytes. Cardiovasc. Res. 1998, 40:174-181.
35. Schluter K.D., Schreiber D. Adult ventricular cardiomyocytes: isolation and culture. Methods Mol. Biol. 2005, 290:305-314.
36. Schluter K.D., Simm A., Schafer M., Taimor G., Piper H.M. Early response kinase and PI 3-kinase activation in adult cardiomyocytes and their role in hypertrophy. Am. J. Physiol. 1999, 276:H1655-H1663.
37. Schluter K.D., Wenzel S. Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks. Pharmacol. Ther. 2008, 119:311-325.
38. Schroder D., Heger J., Piper H.M., Euler G. Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat. J. Mol. Med. 2006, 84:975-983.
39. Sumimoto H. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J. 2008, 275:3249-3277.
40. Sussman M.A., Welch S., Walker A., Klevitsky R., Hewett T.E., Price R.L., Schaefer E., Yager K. Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1. J. Clin. Invest. 2000, 105:875-886.
41. Taimor G., Schluter K., Piper H.M. Hypertrophy-associated gene induction after beta-adrenergic stimulation in adult cardiomyocytes. J. Mol. Cell. Cardiol. 2001, 33:503-511.
42. Takahashi N., Calderone A., Izzo N.J., Maki T.M., Marsh J.D., Colucci W.S. Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes. J. Clin. Invest. 1994, 94:1470-1476.
43. Varon C., Rottiers P., Ezan J., Reuzeau E., Basoni C., Kramer I., Genot E. TGFbeta1 regulates endothelial cell spreading and hypertrophy through a Rac-p38-mediated pathway. Biol. Cell 2008, 100:537-550.
44. Wenzel S., Abdallah Y., Helmig S., Schafer C., Piper H.M., Schluter K.D. Contribution of PI 3-kinase isoforms to angiotensin II- and alpha-adrenoceptor-mediated signalling pathways in cardiomyocytes. Cardiovasc. Res. 2006, 71:352-362.
45. Wenzel S., Henning K., Habbig A., Forst S., Schreckenberg R., Heger J., Maxeiner H., Schlüter K.D. TGF-beta1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes. Basic Res Cardiol. 2010, 105:621-629.
46. Wenzel S., Muller C., Piper H.M., Schluter K.D. p38 MAP-kinase in cultured adult rat ventricular cardiomyocytes: expression and involvement in hypertrophic signalling. Eur. J. Heart Fail. 2005, 7:453-460.
47. Wenzel S., Taimor G., Piper H.M., Schluter K.D. Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes. FASEB J. 2001, 15:2291-2293.
48. Xiao L., Pimentel D.R., Wang J., Singh K., Colucci W.S., Sawyer D.B. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am. J. Physiol. Cell Physiol. 2002, 282:C926-C934.
49. Zhang G.X., Kimura S., Nishiyama A., Shokoji T., Rahman M., Yao L., Nagai Y., Fujisawa Y., Miyatake A., Abe Y. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc. Res. 2005, 65:230-238.
50. Zhao W., Zhao T., Chen Y., Ahokas R.A., Sun Y. Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol. Cell. Biochem. 2008, 317:43-50.